Multiorgan resection for advanced abdominal malignancies - Is it feasible?

Hepato-Gastroenterology

Volumn 54, Issue 77, 2007, Pages 1353-1358

  Lygidakis, N J ^a,b   Bhagat, Anand D ^a   Vrachnos, P ^a   Grigorakos, L ^a  

^a KAT HOSPITAL   (Greece)

^b NONE   (Greece)

Author keywords

Advanced abdominal malignancy; Multi organ resection

Indexed keywords

BEVACIZUMAB; RECOMBINANT INTERLEUKIN 2;

ABDOMINAL CANCER; ADRENALECTOMY; ADULT; ADVANCED CANCER; AGED; ARTICLE; BLEEDING; CANCER ADJUVANT THERAPY; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER SURVIVAL; CARDIOPULMONARY INSUFFICIENCY; CLINICAL EFFECTIVENESS; COLON RESECTION; COLORECTAL CARCINOMA; CONTROLLED STUDY; CYSTECTOMY; FEASIBILITY STUDY; FEMALE; GASTRECTOMY; HUMAN; HUMAN TISSUE; INFERIOR CAVA VEIN; INTESTINE SURGERY; LIVER RESECTION; LOWER ESOPHAGUS SPHINCTER; LUNG EMBOLISM; LUNG INFECTION; MAJOR CLINICAL STUDY; MALE; MORBIDITY; NEPHRECTOMY; OMENTUM; OVARY CARCINOMA; PANCREAS RESECTION; PANCREATITIS; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; QUALITY OF LIFE; RADICAL HYSTERECTOMY; SEPSIS; SPLENECTOMY; STOMACH CARCINOMA; TREATMENT OUTCOME; URINARY TRACT INFECTION; UTERUS CARCINOMA; WOUND INFECTION;

ABDOMINAL NEOPLASMS; ADULT; AGED; AGED, 80 AND OVER; DISEASE PROGRESSION; FEASIBILITY STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES;

EID: 34547645768     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Teo MC, Chow PK, Soo KC: Surgery for retroperitoneal sarcoma requiring major vascular resection and reconstruction. Asian J Surg 2005; 28(4):312-315.
2. Cicala S, Cimino F, Giannone G: Multiple organ resection in advanced gastric carcinoma: experience of 7 years. Suppl Tumori 2005; 4(3):S93. (Italian with English abstract)
3. Settmacher U, Thelen A, Jonas S, Husmann I, Heise M, Neuhaus P: Resection and reconstruction of the retrohepatic vena cava in combination with liver resections. Zentralbl Chir 2005; 130(2): 104-108. (German)
4. Carboni F, Lepiane P, Santoro R, Lorusso R, Mancini P, Sperduti I, Carlini M, Santoro E: Extended multiorgan resection for T4 gastric carcinoma: 25-year experience. J Surg Oncol 2005; 90(2):95-100.
5. Radovanovic D, Stevanovic D, Pavlovic I, Bajec A, Vekic B, Mitrovic N: Multiorgan resection in patients with gastric cancer. Med Pregl 2004; 57(9-10):480-486. (Serbian with English abstract)
6. Colen KL, Marcus SG, Newman E, Berman RS, Yee H, Hiotis SP: Multiorgan resection for gastric cancer: intraoperative and computed tomography assessment of locally advanced disease is inaccurate. J Gastrointest Surg 2004; 8(7):899-902.
7. Pascual Samaniego M, Gonzalez Fajardo JA, Fernandez de la Gandara F, Calleja Escudero J, Sanz Lucas FJ, Fernandez Del Busto E: Giant retroperitoneal liposarcoma. Actas Urol Esp 2003; 27(8):640-644.
8. Martin RC 2nd, Jaques DP, Brennan MF, Karpeh M: Achieving RO resection for locally advanced gastric cancer: is it worth the risk of multiorgan resection? J Am Coll Surg 2002; 194(5):568-577.
9. Yan TD, Esquivel J, Carmignani P, Sugarbaker PH: Cytoreduction and intraperitoneal chemotherapy for the management of non-gynecological peritoneal surface malignancy. J Exp Clin Cancer Res 2003; 22(4 Suppl):109-117.
10. Pomel C, Dauplat J: Management of malignant epithelial tumors of the ovary. J Chir (Paris) 2004; 141(5):277-284. (French with English abstract)
11. Bhoola S, Hoskins WJ: Diagnosis and management of epithelial ovarian cancer. Obstet Gynecol 2006; 107(6):1399-1410.
12. Nam JH, Kim YM, Jung MH, Kim KR, Yoo HJ, Kim DY, Kim JH, Kim YT, Mok JE: Primary peritoneal carcinoma: experience with cytoreductive surgery and combination chemotherapy. Int J Gynecol Cancer 2006; 16(1):23-28.
13. Aletti GD, Dowdy SC, Gostout BS, Jones MB, Stanhope CR, Wilson TO, Podratz KC, Cliby WA: Aggressive surgical effort and improved survival in advanced-stage ovarian cancer. Obstet Gynecol 2006; 107(1):77-85.
14. Sharma S, Driscoll D, Odunsi K, Venkatadri A, Lele S: Safety and efficacy of cytoreductive surgery for epithelial ovarian cancer in elderly and high-risk surgical patients. Am J Obstet Gynecol 2005; 193(6):2077-2082.
15. Hoffman MS, Griffin D, Tebes S, Cardosi RJ, Martino MA, Fiorica JV, Lockhart JL, Grendys EC Jr: Sites of bowel resected to achieve optimal ovarian cancer cytoreduction: implications regarding surgical management. Am J Obstet Gynecol 2005; 193(2):582-586; discussion 586-588.
16. Horowitz NS, Duska LR: Advances in the surgical management of ovarian cancer. J Reprod Med 2005; 50(6):454-466.
17. Cavallari A, Vivarelli M, Bellusci R, Montalti R, De Ruvo N, Cucchetti A, De Vivo A, De Raffele E, Salone M, La Barba G: Liver metastases from colorectal cancer: present surgical approach. Hepatogastroenterology 2003; 50(54):2067-2071.
18. Wright JD, Herzog TJ, Powell MA: Morbidity of cytoreductive surgery in the elderly. Am J Obstet Gynecol 2004; 190(5):1398-400.
19. Chiappa A, Zbar AP, Biffi R, Bellomi M, Orecchia R, Marsiglia H, Bertani E, De Braud F, Crotti C, Andreoni B: Primary and recurrent retroperitoneal sarcoma: factors affecting survival and long-term outcome. Hepatogastroenterology 2004; 51(59):1304-1309.
20. Chikara K, Hiroshi S, Masato N, Hirotoshi A, Goro M, Hidetaka O: Indications for pancreaticosplenectomy in advanced gastric cancer. Hepatogastroenterology 2001; 48(39):908-912.
21. Lygidakis NJ, Singh G, Bardaxoglou E, Dedemadi G, Sgourakis G, Nestoridis J, Malliotakis A, Pedonomou M, Solomou EK, Safioleas M, Alamani M, Grigorakos L, Merikas EM: Mono-bloc total spleno-pancreaticoduodenectomy for pancreatic head carcinoma with portal-mesenteric venous invasion. A prospective randomized study. Hepatogastroenterology 2004; 51(56):427-433.
22. Lygidakis NJ, et al: Two-stage liver surgery for advanced liver metastasis synchronous with colorectal tumor. Hepatogastroenterology 2004; 51(56):413-418.
23. Janciauskiene R, Juozaityte E, Pavalkis D: The role of the regional (intra-arterial) chemo therapy in the treatment of hepatic metastases of colorectal cancer Medicina (Kaunas) 2003; 39(1):5-14. (Lithuanian with English abstract)